CLOVER HEALTH INVESTMENTS CO (CLOV)
US18914F1030 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | 28.00M | 0.00 | |||
| Cash Equivalents | 122.86M | 103.80M | 300.00M | N/A | N/A | |||
| Marketable Securities | 175.45M | 331.50M | 327.90M | N/A | N/A | |||
| Receivables | 91.76M | 147.20M | 62.30M | N/A | N/A | |||
| Other Current Assets | 37.90M | 42.50M | 62.30M | 300.00K | N/A | |||
| Total Current Assets | 427.97M | 625.00M | 752.50M | 28.30M | 0.00 | |||
| Non-Current Assets | ||||||||
| PPE Net | 8.46M | 9.80M | 7.70M | N/A | N/A | |||
| Investments And Advances | 121.00M | 138.10M | 175.90M | 828.10M | N/A | |||
| Intangibles | 2.99M | 20.00M | 4.20M | N/A | N/A | |||
| Other Non-Current Assets | 10.25M | 15.70M | 10.40M | 0.00 | 100.00K | |||
| Total Non-Current Assets | 142.70M | 183.60M | 198.30M | 828.10M | N/A | |||
| TOTAL ASSETS | 570.67M | 808.60M | 950.80M | 856.40M | 100.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 800.00K | 0.00 | |||
| Accrued Expenses | 22.73M | 25.80M | 18.20M | 5.10M | 100.00K | |||
| Accounts Payable | 37.18M | 32.40M | 28.10M | N/A | N/A | |||
| Other Current Liabilities | 201.21M | 373.30M | 326.30M | 28.00M | N/A | |||
| Total Current Liabilities | 261.12M | 431.50M | 372.60M | 33.90M | 100.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 19.90M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 23.16M | 20.20M | 18.90M | 29.00M | N/A | |||
| Total Non-Current Liabilities | 23.16M | 20.20M | 42.80M | 29.00M | 0.00 | |||
| TOTAL LIABILITIES | 284.28M | 451.70M | 415.40M | 62.90M | 100.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -2.16B | -1.95B | -1.62B | -6.80M | 0.00 | |||
| Additional Paid In Capital | 2.46B | 2.32B | 2.15B | 11.80M | 0.00 | |||
| Minority Interest | N/A | 0.00 | 3.90M | N/A | N/A | |||
| Common Shares | 49.00K | 0.00 | 0.00 | 788.50M | 0.00 | |||
| Treasury Stock | -12.73M | -6.50M | -100.00K | N/A | N/A | |||
| Other Shareholders' Equity | -2.37M | -9.40M | -1.90M | N/A | N/A | |||
| Shares Outstanding | 489.05M | 478.40M | 470.90M | 103.50M | 75.00M | |||
| Tangible Book Value per Share | 0.58 | 0.70 | 1.13 | 7.67 | 0.00 | |||
| Total Shareholders' Equity | 286.39M | 356.90M | 535.40M | 793.50M | 0.00 | |||
| TOTAL LIABILITIES AND EQUITY | 570.67M | 808.60M | 950.80M | 856.40M | 100.00K | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | 0.04 | N/A | N/A | |||
| Current Ratio | 1.64 | 1.45 | 2.02 | 0.83 | N/A | |||
| Return On Assets (ROA) | -37.39% | -41.90% | -61.82% | -0.78% | N/A | |||
| Return On Equity (ROE) | -74.50% | -94.93% | -109.79% | -0.84% | N/A | |||
All data in USD